1. |
Wan MS, Fell PL, Akhtar S. Synthetic 2’Omethylmodified hammerhead ribozymes targeted to the RNA component of telomerase as sequencespecific inhibitors of telomerase activity [J]. Antisense Nucleic Acid Drug Dev, 1998; 8(4)∶309.
|
2. |
Li QX, Robbins JM, Welch PJ, et al. A novel functional genomics approach identifies mTERT as a suppressor of fibroblast transformation [J]. Nucleic Acids Res, 2000; 28(13)∶2605.
|
3. |
Kanazawa Y, Ohkawa K, Ueda K, et al. Hammerhead ribozymemediated inhibition of telomerase activity in extracts of human hepatocellular carcinoma cells [J]. Biochem Biophys Res Commun, 1996; 225(2)∶570.
|
4. |
DeYoung M, Siwkowski AM, Lian Y, et al. Catalytic properties of hairpin ribozymes derived from Chicory yellow mottle virus and arabis mosaic virus satellite RNAs [J]. Biochemistry, 1995; 34(48)∶15785.
|
5. |
Feng J, Funk WD, Wang SS, et al. The RNA component of human telomerase [J]. Science, 1995; 269(5228)∶1236.
|
6. |
Greider CW. Telomerase activity, cell proliferation, and cancer [J]. Proc Natl Acad Sci USA, 1998; 95(1)∶90.
|
7. |
Yokoyama Y, Takahashi Y, Shinohara A, et al. Attenuation of telomerase activity by a hammerhead ribozyme targeting the template region of telomerase RNA in endometrial carcinoma cells [J]. Cancer Res, 1998; 58(23)∶5406.
|
8. |
Cech TR. Ribozymes, the first 20 years [J]. Biochem Soc Trans, 2002; 30(6)∶1162.
|